ASIA PACIFIC SILK ROAD INVESTMENT CO LTD

Add to a list

Inactive Instrument

Asia Pacific Silk Road Investment Co Ltd Stock Hong Kong S.E.

0767

BMG6853V2817

Valuation : Asia Pacific Silk Road Investment Co Ltd

Market Cap	331M 42.23M 36.39M 34.12M 31.14M 58.67M 4.04B 58.85M 405M 158M 2.04B 159M 155M 6.76B	P/E 2024	-3.29x	P/E 2025	-17.7x
Enterprise Value	312M 39.84M 34.33M 32.19M 29.38M 55.35M 3.81B 55.52M 382M 149M 1.92B 150M 146M 6.37B	EV / Sales 2024	0.56x	EV / Sales 2025	2.38x
Free-Float	46.65%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Asia Pacific Silk Road Investment Co Ltd

08-27	Zhong Ji Longevity Science Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-13	Zhong Ji Longevity to Form AI Vision Health JV Firm	MT
04-13	Zhong Ji Longevity Science's unit entered into JV agreement with Guangdong Liangjingjing Technology	RE
03-26	Zhong Ji Longevity Science posts FY loss attributable HK$16.8 million	RE
03-26	Zhong Ji Longevity Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-10	Zhong Ji Longevity Science Group Limited Announces Appointment of Ms. Tam Mei Chu as Independent Non-Executive Director and Audit Committee, Remuneration Committee, Nomination Committee, the Risk Management Committee and the Share Award Committee Member, Effective February 10, 2026	CI
12-02	Zhong Ji Longevity Science to Buy 25% Stake in Boutique Stem Cell Center	MT
12-01	Zhong Ji Longevity Science to buy 25% of Asian Integrated Cell Laboratory at HK$300 million	RE
11-27	Zhong Ji Longevity Science Group Limited Announces Board and Committee Changes, Effective 27 November 2025	CI
25-10-20	Zhong Ji Longevity's CEO Steps Down, Successor Named; Shares Jump 4%	MT
25-10-17	Zhong Ji Longevity Science appoints Yan Li as CEO	RE
25-10-17	Zhong Ji Longevity Science Group Limited Announces Chief Executive Officer Change, Effective from 17 October 2025	CI
25-10-17	Zhong Ji Longevity Science Group Limited Announces Board Changes, Effective from 17 October 2025	CI

More news

Press Releases : Asia Pacific Silk Road Investment Co Ltd

21-08-30	Zhong Ji Longevity Science : Announces 2021 Interim Results	AQ
21-05-12	Zhong Ji Longevity Science : VOLUNTARY ANNOUNCEMENT REGISTRATION OF IMPORTANT PATENTS RELATED TO CANCER SCREENING APPROVED BY THE PATENT REGISTRY OF THE INTELLECTUAL PROPERTY DEPARTMENT OF THE GOVERNMENT OF THE HONG KONG SPECIAL ADMINISTRATIVE REGION	PU
21-05-12	Zhong Ji Longevity Science : VOLUNTARY ANNOUNCEMENT COOPERATION AGREEMENT	PU
21-05-12	Zhong Ji Longevity Science : (1) PLACING OF NEW SHARES UNDER GENERAL MANDATE; AND (2) CONNECTED TRANSACTION IN RELATION TO SUBSCRIPTION OF NEW SHARES UNDER SPECIFIC MANDATE	PU
21-04-30	Zhong Ji Longevity Science : CHANGE OF DIRECTORS APPOINTMENT OF CHIEF EXECUTIVE OFFICER CHANGES OF MEMBERS OF BOARD COMMITTEES AND CHANGE OF AUTHORISED REPRESENTATIVE	PU

More press releases

Managers and Directors : Asia Pacific Silk Road Investment Co Ltd

Manager	Title	Age	Since
Li Yan CEO	Chief Executive Officer	54	2025-10-16
Ning Chen CIO	Chief Investment Officer	51	2022-02-27
Yuk Hong Yeung SEC	Corporate Secretary	36	2023-05-30

Director	Title	Age	Since
Li Yan CHM	Chairman	54	2020-12-15
Yi Wu He BRD	Director/Board Member	61	2021-08-12
Xiaoshuang Li BRD	Director/Board Member	51	2021-08-30

More insiders

Zhong Ji Longevity Science Group Ltd, formerly Asia Pacific Silk Road Investment Co Ltd, is an investment holding company principally engaged in the longevity science and money lending business. The Company mainly operates its business through five segments. The Longevity Science segment is engaged in longevity science research, longevity medical testing, longevity biological products, longevity management services and member division. The Money Lending segment is engaged in the money lending business and the provision of credits. The Securities and Other Investment segment is mainly engaged in the holding of equity investments and investment in short to long-term financial assets. The Property Investment segment is mainly engaged in the investment in properties for rental income and for potential capital appreciation. The Financial and Investment Advisory segment is mainly engaged in the provision of financial and investment consulting services.

Employees

Sector

Consumer Lending

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ASIA PACIFIC SILK ROAD INVESTMENT CO LTD	-.--%	-.--%	-	-	42.23M
BAJAJ FINANCE LIMITED	-0.29%	-1.38%	+23.16%	+49.25%	70.26B
ROCKET COMPANIES, INC.	-3.30%	-1.15%	-23.03%	+31.90%	38.99B
BAJAJ FINSERV LTD.	-0.45%	-1.50%	+4.40%	+33.48%	33.49B
SHRIRAM FINANCE LIMITED	-1.67%	-4.45%	+89.49%	+190.62%	26.68B
SYNCHRONY FINANCIAL	-2.35%	-1.79%	+1.92%	+144.06%	25.4B
SOFI TECHNOLOGIES, INC.	-5.84%	-4.49%	-30.65%	+119.44%	23.33B
CHOLAMANDALAM INVESTMENT AND FINANCE COMPANY LIMITED	-1.60%	-0.54%	+28.48%	+69.19%	16.53B
TATA CAPITAL LIMITED	-0.08%	+2.92%	-	-	16.58B
JIO FINANCIAL SERVICES LIMITED	+0.13%	-2.30%	-23.12%	+12.91%	16.47B
Average	-0.64%	-1.34%	+8.83%	+81.35%	29.75B
Weighted average by Cap.	-0.58%	-1.22%	+10.70%	+74.50%

	2024	2025
Net sales	169M 21.51M 18.53M 17.38M 15.86M 29.88M 2.06B 29.98M 206M 80.44M 1.04B 80.75M 78.99M 3.44B	126M 16.08M 13.86M 12.99M 11.86M 22.35M 1.54B 22.42M 154M 60.15M 776M 60.39M 59.07M 2.57B
Net income	-34.73M -4.43M -3.82M -3.58M -3.27M -6.15M -423M -6.17M -42.46M -16.56M -214M -16.63M -16.27M -709M	-16.75M -2.14M -1.84M -1.73M -1.58M -2.97M -204M -2.98M -20.48M -7.99M -103M -8.02M -7.85M -342M
Net Debt	-28.73M -3.66M -3.16M -2.96M -2.7M -5.09M -350M -5.11M -35.13M -13.71M -177M -13.76M -13.46M -586M	-18.73M -2.39M -2.06M -1.93M -1.76M -3.32M -228M -3.33M -22.9M -8.94M -115M -8.97M -8.78M -382M

Asia Pacific Silk Road Investment Co Ltd Stock Hong Kong S.E.

Stocks